medical Class II Updated 2023-09-06

Siemens Healthcare Diagnostics, Inc. recalls Atellica CH Triglycerides_2: in vitro diagnostic use in the

Recalled Product

Atellica CH Triglycerides_2: in vitro diagnostic use in the quantitative determination of triglycerides in human serum and plasma (lithium heparin, sodium heparin, potassium EDTA) using the Atellica CH Analyzer. SMN: 11537222


Hazard / Issue

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: UDI: 00630414610955 All Lots
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →